Patient safety first
Clinicians are being more proactive about identifying patients with Atrial Fibrillation (AF), but how do you ensure that those patients who should be prescribed anticoagulants are receiving the safest, most appropriate treatment?
“With more than 10% of over 65 year olds having AF, GPs have to deal with both its identification and management on a regular basis. The NICE guideline builds on the relationship between the patient with AF and their GP, outlining how each patient should have a clear management plan…”*
Dr Matthew Fay FRCP (Edin.), GP Principal, Westcliffe Medical Practice
How do you ensure you are offering safe, effective anticoagulation support?
INRstar supports clinicians to monitor AF patients’ INR levels. With it’s range of features INRstar supports you to run a safe and efficient anticoagulation service for patients of all diagnoses. Software features include clinically risk assessed roles and permissions, reports, External Patient Lookup, INRstar analytics, NOACs monitoring, clinical system integration and our HL7 interface.
Discover more about how INRstar features can help you to put patient safety first
Rigorous safety and risk assessment criteria
We are passionate about improving patient outcomes and continually improve our software to ensure it meets the most rigorous safety and risk assessment criteria including:
- Full compliance with the European Medical Device Directive (93/42/EEC)
- Online webinar training sessions
- Tools and reports that enable you to meet National Patient Safety Agency (NPSA) compliance and follow NICE guidelines on anticoagulation management
- Clinically risk assessed by medical professionals
- Continuity of care and management of safety issues associated with transfer from Secondary into Primary Care and vice versa